2022
DOI: 10.3390/ijms23116037
|View full text |Cite
|
Sign up to set email alerts
|

PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression

Abstract: This study aimed to investigate the role of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 (PLOD2) in glioblastoma (GBM) pathophysiology. To this end, PLOD2 protein expression was assessed by immunohistochemistry in two independent cohorts of patients with primary GBM (n1 = 204 and n2 = 203, respectively). Association with the outcome was tested by Kaplan–Meier, log-rank and multivariate Cox regression analysis in patients with confirmed IDH wild-type status. The biological effects and downstream mechanism… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 58 publications
(85 reference statements)
0
6
0
Order By: Relevance
“…A previous scRNA-seq analysis revealed SPP1/CD44-mediated crosstalk between macrophages and cancer cells in glioma ( 44 ). PLOD2 modulates the immune microenvironment and tumor progression of glioma, in which CD44 was the critical downstream molecule ( 45 ). Besides, CD44 was recently demonstrated to be associated with the M2-polarization of tumor-associated macrophages and immunosuppression of glioma ( 25 ).…”
Section: Discussionmentioning
confidence: 99%
“…A previous scRNA-seq analysis revealed SPP1/CD44-mediated crosstalk between macrophages and cancer cells in glioma ( 44 ). PLOD2 modulates the immune microenvironment and tumor progression of glioma, in which CD44 was the critical downstream molecule ( 45 ). Besides, CD44 was recently demonstrated to be associated with the M2-polarization of tumor-associated macrophages and immunosuppression of glioma ( 25 ).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, evaluation of local and safe administration of targeted pharmacotherapeutics designed to weaken fibrous COL1 deposits in the synovium and neighboring fibro-sensitive structures such as the peri-articular musculature is critical to improve on the success of physical therapy, manual or device-assisted MUA, and arthroscopic lysis of adhesions. As an FDA-approved pharmacotherapeutic, elucidating the antifibrotic potential of MXD to modulate Pyd cross-linking in COL1 fibrous networks in fibroproliferative diseases such as idiopathic pulmonary fibrosis, renal disease, dermal scarring, and metastatic neoplasms in vitro needs further evaluation within the musculoskeletal arena beyond its shown effect on clubfoot fibroblasts [ 13 , 21 , 22 , 31 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…The LH activity plays an important role in the ability of tumor cells to invade and metastasize through the modification of the extracellular matrix. A growing number of articles present increased LH expression as a prognostic marker associated with poor prognosis in patients with osteosarcoma [ 68 ], glioblastoma [ 27 ], oral squamous cell carcinoma [ 25 , 69 ], and other cancer diseases. Moreover, neutrophils that were attached to fibronectin in the presence of ivermectin did not secrete MMPs ( Figure 6 , Table 1 ).…”
Section: Discussionmentioning
confidence: 99%
“…In tumor cells, LH is also secreted and functions in the extracellular space [ 17 , 18 , 19 ], thus affecting cell migration and adhesion via modification of the extracellular matrix [ 20 ]. A growing number of studies demonstrate that LH activity correlates with the ability of tumor cells to invade and metastasize [ 21 , 22 , 23 , 24 , 25 , 26 , 27 ]. By analogy with tumor cells, we hypothesize that the adhesion-induced increase in hydroxylysine release is associated with an increase in LH activity designed to promote neutrophil infiltration into tissues.…”
Section: Introductionmentioning
confidence: 99%